At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
03880 MEDTIDE
Market Closed 08-07 16:05:16
20.620
+0.120
+0.59%
High21.240
Low20.420
Vol102.20K
Open20.500
D1 Closing20.500
Amplitude4.00%
Mkt Cap2.92B
Tradable Cap2.92B
Total Shares141.80M
T/O2.13M
T/O Rate0.07%
Tradable Shares141.80M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Hong Kong Stock CXO Sector Rallies; Will MEDTIDE (03880) Defy the Trend or Bounce Back After Its Profit Warning?
Cpc Scientific Announces U.S. FDA Pre-License Inspection (Pli) Successfully Completed at Its Hangzhou Cgmp Manufacturing Facility for Hepcludex® API, Establishing a Proven Track Record Under the Stringent Bla Pathway
Medtide Inc is a China-based company mainly engaged in the contract research, development and manufacturing of peptide. The Company mainly provides contract research organization (CRO) services, namely peptide new chemical entity (NCE) discovery synthesis, contract development and manufacturing organization (CDMO) services, namely peptide chemistry, manufacturing, and control (CMC) development and commercial manufacturing. The Company's services primarily focus on providing customers with active pharmaceutical ingredients (APIs) rather than drug products. The Company also provides customers with peptide drug development, production, and CMC filing support services. The Company mainly operates its business in the domestic market and overseas markets.